PE20070122A1 - Proceso para preparar derivados de piperazina azindoloxoacetica sustituida con triazol y nuevas formas de sal producidas de los mismos - Google Patents

Proceso para preparar derivados de piperazina azindoloxoacetica sustituida con triazol y nuevas formas de sal producidas de los mismos

Info

Publication number
PE20070122A1
PE20070122A1 PE2006000714A PE2006000714A PE20070122A1 PE 20070122 A1 PE20070122 A1 PE 20070122A1 PE 2006000714 A PE2006000714 A PE 2006000714A PE 2006000714 A PE2006000714 A PE 2006000714A PE 20070122 A1 PE20070122 A1 PE 20070122A1
Authority
PE
Peru
Prior art keywords
azindoloxoacetica
triazole
piperazine
substituted
new forms
Prior art date
Application number
PE2006000714A
Other languages
English (en)
Inventor
Nachimuthu Soundararajan
Yuping Qiu
Wenhao Hu
Pierre Sirard
Roberto Droghini
Xinhua Qian
Shawn K Pack
Michael G Fakes
Feng Qian
Shan-Ming Kuang
Chiajen Lai
Blisse J Vakkalagadda
Qi Gao
Erquing Tang
Natalie
Ramakrishnan Chidambaram
Jean Lajeunesse
David R Kronenthal
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20070122A1 publication Critical patent/PE20070122A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA A, B, C, D ENTRE OTROS DONDE R18 ES H, ALQUILO; R1, R2 Y R3 SON CADA UNO H, HALOGENO, CIANO, NITRO, ENTRE OTROS. UN COMPUESTO PREFERIDO ES II. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A PROCEDIMIENTOS DE PREPRACION DE LOS COMPUESTOS MENCIONADOS. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DEL SIDA
PE2006000714A 2005-06-22 2006-06-22 Proceso para preparar derivados de piperazina azindoloxoacetica sustituida con triazol y nuevas formas de sal producidas de los mismos PE20070122A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69300405P 2005-06-22 2005-06-22

Publications (1)

Publication Number Publication Date
PE20070122A1 true PE20070122A1 (es) 2007-03-11

Family

ID=37460063

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000714A PE20070122A1 (es) 2005-06-22 2006-06-22 Proceso para preparar derivados de piperazina azindoloxoacetica sustituida con triazol y nuevas formas de sal producidas de los mismos

Country Status (11)

Country Link
US (2) US7601715B2 (es)
EP (1) EP1907389B1 (es)
JP (1) JP5010593B2 (es)
CN (1) CN101243085A (es)
AR (1) AR055801A1 (es)
AT (1) ATE517898T1 (es)
ES (1) ES2368788T3 (es)
NO (1) NO341136B1 (es)
PE (1) PE20070122A1 (es)
TW (1) TW200740807A (es)
WO (1) WO2007002308A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601715B2 (en) * 2005-06-22 2009-10-13 Bristol-Myers Squibb Company Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
US7598380B2 (en) * 2005-08-03 2009-10-06 Bristol-Myers Squibb Company Method of preparation of azaindole derivatives
EP2303014A4 (en) * 2008-07-08 2011-07-20 Richter Gedeon Nyrt NOVEL CRYSTALLINE FORM OF 2-Ý4 (4-FLUOROBENZYL) PIPERIDIN-1-YL-2-OXO-N- (2-OXO-2,3-DIHYDROBENZOXAZOL-6-YL) ACETAMIDE
PL2323633T3 (pl) * 2008-09-04 2012-08-31 Viiv Healthcare Uk No 4 Ltd Stabilna kompozycja farmaceutyczna dla zoptymalizowanego dostarczania inhibitora zaczepu HIV
BR112012024705A2 (pt) 2010-03-31 2016-06-07 Actelion Pharmaceuticals Ltd derivados antibacterianos de isoquinolin-3-ilureia
WO2011130500A1 (en) * 2010-04-16 2011-10-20 Novartis Ag Formulations of a pyridazine bipyrazinyl
US20110263701A1 (en) * 2010-04-21 2011-10-27 Sigal Blau Gabapentin enacarbil compositions
CN102372707B (zh) * 2010-08-16 2015-08-19 上海药明康德新药开发有限公司 6-甲基-4-溴-1,6-二氢吡咯[2,3-c]吡啶-7-酮的合成方法
SI2670751T1 (sl) 2011-01-31 2015-07-31 Bristol-Myers Squibb Company Metode za izdelovanje HIV pritrditvene inhibitorne spojine predzdravila in intermediati
CN102993109A (zh) * 2012-12-03 2013-03-27 浙江工业大学 一种脒化合物的制备方法
NZ720340A (en) 2013-12-05 2020-03-27 Hoffmann La Roche Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crystalline forms thereof
AR099677A1 (es) 2014-03-07 2016-08-10 Sumitomo Chemical Co Compuesto heterocíclico fusionado y su uso para el control de plagas
CN108863917A (zh) * 2017-05-16 2018-11-23 穆云 一种2,5-二甲氧基吡啶的制备方法
US20220106341A1 (en) 2019-01-17 2022-04-07 Viiv Healthcare Uk (No. 4) Limited Process for preparing fostemsavir

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3545461B2 (ja) * 1993-09-10 2004-07-21 エーザイ株式会社 二環式ヘテロ環含有スルホンアミド誘導体
ZA949293B (en) 1993-12-08 1995-08-17 Nihon Nohyaku Co Ltd Hydrazine derivatives and uses thereof
US20020061892A1 (en) 2000-02-22 2002-05-23 Tao Wang Antiviral azaindole derivatives
US6476034B2 (en) * 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20030207910A1 (en) 2001-02-02 2003-11-06 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
CN100384423C (zh) 2001-02-02 2008-04-30 布里斯托尔-迈尔斯斯奎布公司 取代的氮杂吲哚氧代乙酰哌嗪衍生物的组合物和抗病毒活性
US20040063744A1 (en) 2002-05-28 2004-04-01 Tao Wang Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
US7745625B2 (en) * 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7601715B2 (en) 2005-06-22 2009-10-13 Bristol-Myers Squibb Company Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein

Also Published As

Publication number Publication date
WO2007002308A2 (en) 2007-01-04
US20100076191A1 (en) 2010-03-25
WO2007002308A3 (en) 2007-07-12
WO2007002308A9 (en) 2007-03-01
JP5010593B2 (ja) 2012-08-29
NO20076575L (no) 2008-03-18
CN101243085A (zh) 2008-08-13
US7968718B2 (en) 2011-06-28
TW200740807A (en) 2007-11-01
US20060293304A1 (en) 2006-12-28
ATE517898T1 (de) 2011-08-15
AR055801A1 (es) 2007-09-05
JP2008546795A (ja) 2008-12-25
EP1907389B1 (en) 2011-07-27
ES2368788T3 (es) 2011-11-22
NO341136B1 (no) 2017-08-28
EP1907389A2 (en) 2008-04-09
US7601715B2 (en) 2009-10-13

Similar Documents

Publication Publication Date Title
PE20070122A1 (es) Proceso para preparar derivados de piperazina azindoloxoacetica sustituida con triazol y nuevas formas de sal producidas de los mismos
PE20170189A1 (es) Nuevos derivados de pirazolo pirimidina y su uso como inhibidores de malt1
CR9459A (es) Derivados benzodioxano y benzodioxolano y usos de los mismos
PA8593101A1 (es) Composiciones para el tratamiento de crecimiento celular anormal
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
ECSP105253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
PE20080948A1 (es) Derivados de imidazol como moduladores de la senda de hedgehog
CL2021002519A1 (es) Compuestos de diazina-amida activos como pesticidas.
RS53293B (en) CYTOTOXIC AGENTS CONTAINING NEW TOMAIMYCIN DERIVATIVES AND THEIR THERAPY
PE20190656A1 (es) Compuestos de tiazolo-piridina sustituida como inhibidores de malt1
UY29393A1 (es) Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones.
PA8680701A1 (es) Derivados de oxindol
AR047538A1 (es) Piridazinonas como antagonistas de las integrinas alfa4
UY27055A1 (es) Activadores heteroaromaticos fusionados de la glucoquinasa
PE20060504A1 (es) Derivados de pirimidina en el tratamiento de cancer
ECSP088511A (es) Agonistas del receptor del neuropeptido-2
PE20141700A1 (es) Compuestos de 2-(2,4,5-anilino sustituido) pirimidina
SE0302486D0 (sv) Novel compounds
CU23550B7 (es) Derivados de pirrolo-pirazol sustituidos como inhibidores de quinasa
PE20170946A1 (es) 2-amino-6-(difluorometil)- 5,5-difluoro-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1
UY28885A1 (es) 4-fenilamino-quinazolin-6-il-amidas referencia cruzada a solicitud(es) relacionada(s)
ECSP088145A (es) Derivados bicíclicos como inhibidores de la cinasa p38
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
PE20210373A1 (es) Compuestos de pirimidina y composiciones farmaceuticas para prevenir o tratar canceres que incluyen los mismos
AR067996A1 (es) Derivados heterociclicos de ciclopropano,composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento de afecciones asociadas a receptores de histamina h3, tales como enfermedad de alzheimer y esquizofrenia,entre otros.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal